Assignee
GUANGZHOU BIO GENE TECH CO LTD
CN·4 granted patents·3 pending applications·1 citations·filing 2019–2021
Top patents by PatentIndex Score
7 records- 0178US12358990B2Anti-CLL1 antibody and use thereofGUANGZHOU BIO GENE TECH CO LTD·Filed 2020·Granted Jul 15, 2025·1 cites·24 claims
- 0254US12508312B2Chimeric antigen receptor targeting CLL1 and use thereofGUANGZHOU BIO GENE TECH CO LTD·Filed 2020·Granted Dec 30, 2025·0 cites·20 claims
- 0353US12595308B2Anti-B7H3 antibody and use thereofGUANGZHOU BIO GENE TECH CO LTD·Filed 2020·Granted Apr 7, 2026·0 cites·11 claims
- 0448US2024122982A1Chimeric antigen receptor fusion protein co-expressing il-7 and ccr2b, and application thereofGUANGZHOU BIO GENE TECH CO LTD·Filed 2021·Application pending·0 cites
- 0547US11542318B2Use of chemokine receptor CXCR5GUANGZHOU BIO GENE TECH CO LTD·Filed 2019·Granted Jan 3, 2023·0 cites·13 claims
- 0646US2024059776A1Anti-b7h3 chimeric antigen receptor and application thereofGUANGZHOU BIO GENE TECH CO LTD·Filed 2020·Application pending·0 cites
- 0746US2024050472A1Anti-claudin18.2 antigen-binding fragment or antibody, and use thereof18255119GUANGZHOU BIO GENE TECH CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GUANGZHOU BIO GENE TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →